70PMP may issue VAD substance prescription

### 70 PMP may issue VAD substance prescription > > (1)  A PMP to whom a VAD substance authorisation in relation to a person is issued under [section 67(1)(a)](#GS67@Gs1@Hpa@EN)  – > > > > > > (a) may issue a VAD substance prescription in relation to the person, containing the relevant prescription details in respect of the person, if the PMP is authorised to do so under [subsection (2)(a)](#GS70@Gs2@Hpa@EN) ; and > > > > > > > (b) may request and receive from a pharmacist, in accordance with the VAD substance prescription, the amount of the VAD substance specified in the VAD substance prescription, if the PMP is authorised to do so under [subsection (2)(b)](#GS70@Gs2@Hpb@EN) . > > > (2)  A PMP to whom a VAD substance authorisation in relation to a person is issued under [section 67(1)(a)](#GS67@Gs1@Hpa@EN)  – > > > > > > (a) is authorised to issue a VAD substance prescription, containing the relevant prescription details in respect of the person, unless, before the prescription is issued – > > > > > > > > > > (i) the VAD substance authorisation has been revoked under [section 69](#GS69@EN) ; or > > > > > > > > > > > (ii) the person has informed the PMP under [section 16(1)](#GS16@Gs1@EN) that the person no longer wishes to access voluntary assisted dying; or > > > > > > > > > > > (iii) the PMP has been notified under [section 16(5)(b)](#GS16@Gs5@Hpb@EN) by the AHP in relation to the person that the person no longer wishes to access voluntary assisted dying; and > > > > > > > (b) is authorised to request and receive from a pharmacist, as the agent of the person to whom the relevant prescription details relate, the amount of the VAD substance specified in the VAD substance prescription, unless, before the substance is requested or received – > > > > > > > > > > (i) the VAD substance authorisation has been revoked under [section 69](#GS69@EN) ; or > > > > > > > > > > > (ii) the person has, under [section 16(1)](#GS16@Gs1@EN) , informed the PMP in relation to the person that the person no longer wishes to access voluntary assisted dying; or > > > > > > > > > > > (iii) the PMP has been notified under [section 16(5)(b)](#GS16@Gs5@Hpb@EN) by the AHP in relation to the person that the person no longer wishes to access voluntary assisted dying. > > > (3)  For the purposes of this section, the relevant prescription details in respect of a person are – > > > > > > (a) the name of the person and the address at which the person is ordinarily resident; and > > > > > > > (b) the name of the PMP who has issued the VAD substance prescription; and > > > > > > > (c) the details of the VAD substance to which the VAD substance prescription relates, being the VAD substance specified in the VAD substance authorisation; and > > > > > > > (d) the maximum amount of the VAD substance, the supply and possession of which is authorised by the VAD substance prescription.